- Home
- HAE
as 12-17-2024 4:00pm EST
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company places primary emphasis on its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.
| Founded: | 1971 | Country: | United States |
| Employees: | N/A | City: | BOSTON |
| Market Cap: | 4.4B | IPO Year: | 1991 |
| Target Price: | $108.78 | AVG Volume (30 days): | 494.4K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 9 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 2.41 | EPS Growth: | -3.24 |
| 52 Week Low/High: | $70.25 - $97.97 | Next Earning Date: | 02-06-2025 |
| Revenue: | $1,361,223,000 | Revenue Growth: | 9.84% |
| Revenue Growth (this year): | 7.63% | Revenue Growth (next year): | 4.40% |
Latest Haemonetics Corporation News
HAE Breaking Stock News: Dive into HAE Ticker-Specific Updates for Smart Investing
Zacks
20 hours ago
Reasons to Retain STE Stock in Your Portfolio Now
Zacks
a day ago
Bioproduction Prospects to Drive TMO Shares Despite Macroeconomic Woes
Zacks
a day ago
SNN Stock Might Rise Following FDA Nod for AETOS Stemless
Zacks
a day ago
LH Stock May Gain From Select MAWD Pathology Asset Purchase Deal
Zacks
a day ago
Is Myriad Genetics Stock a Smart Hold for Your Portfolio Right Now?
Zacks
2 days ago
Teleflex Expands CVC Portfolio in EMEA With New Launch: Stock to Gain?
Zacks
5 days ago
Is it Apt to Hold Edwards Lifesciences Stock in Your Portfolio Now?
Zacks
5 days ago
Reasons to Retain Alcon Stock in Your Portfolio for Now
Compare HAE vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "HAE Haemonetics Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.